Filière de Santé Maladies Rares du Foie - FILFOIE

Construire sa base de données - Les Mercredis FILFOIE #3

FILFOIE Wednesdays 3

Formation sur le Guide du codage FILFOIE

Training on the FILFOIE Coding Guide

Les différents types de recherches et leurs réglementations - Les Mercredis FILFOIE #2

The different types of research and their regulations - FILFOIE Wednesdays #2

Aide méthodologique et statistiques de vos projets de recherche - Les Mercredis FILFOIE #1

Methodological assistance and statistics for your research projects - Les Mercredis FILFOIE #1

REPLAY - Webinaire sur les Maladies Vasculaires du Foie

REPLAY - Webinar on Vascular Liver Diseases

LPAC : Physiopathologie, épidémiologie, diagnostic et traitement médical - JAMRF25

LPAC: Pathophysiology, Epidemiology, Diagnosis and Medical Treatment - JAMRF25

Diagnostic génétique du LPAC – JAMRF25

Genetic diagnosis of LPAC – JAMRF25

Traitement endoscopique du LPAC – JAMRF25

Endoscopic treatment of LPAC – JAMRF25

Table ronde santé sexuelle : Questions-réponses en sexologie – JAMRF25

Sexual Health Roundtable: Questions and Answers in Sexology – JAMRF25

Table ronde santé sexuelle : Impact sur la qualité de vie – JAMRF25

Sexual Health Roundtable: Impact on Quality of Life – JAMRF25

Ressenti du patient atteint de LPAC – JAMRF25

Patient experience with LPAC – JAMRF25

Prix FILFOIE : Pharmacothérapie ciblée des variants ABCB4 – JAMRF25

FILFOIE Prize: Targeted Pharmacotherapy of ABCB4 Variants – JAMRF25

Groupes de Travail FILFOIE : Recherche – JAMRF25

FILFOIE Working Groups: Research – JAMRF25

Fil rouge FILFOIE : Hommage à Olivier Chazouillières – JAMRF25

FILFOIE's central theme: A tribute to Olivier Chazouillières – JAMRF25

Actualités du réseau MIVB-H – JAMRF25

MIVB-H Network News – JAMRF25

Actualités des associations de patients – JAMRF25

Patient association news – JAMRF25

When should PSVD be suspected - Paris PSVD Meeting

Surrogate markers of outcome in PSVD: do’s and don’ts - Paris PSVD Meeting

Specificities of PSVD in children and transition to adulthood - Paris PSVD Meeting

PSVD without portal hypertension - Paris PSVD Meeting

Prognostic and natural history of PSVD with signs of portal - Paris PSVD Meeting

Preclinical models of PSVD - Paris PSVD Meeting

Pathophysiology: is PSVD an immune, a vascular or a coagulation disorder? - Paris PSVD Meeting

Pathological changes in PSVD: current view and future directions – Paris PSVD Meeting

Novel therapies and therapeutic approaches - Paris PSVD Meeting

Nodules in PSVD - Paris PSVD Meeting

Management of portal hypertension complications in PSVD - Paris PSVD Meeting

Liver transplantation in PSVD - Paris PSVD Meeting

Innovative trial design for rare diseases - Paris PSVD Meeting

Inclusion criteria for studies on PSVD - Paris PSVD Meeting

Imaging and PSVD: improving diagnosis and prognosis – Paris PSVD Meeting

Hemodynamic changes in PSVD and their modulation - Paris PSVD Meeting

Health-related quality of life (HRQOL) and PRO in PSVD – Paris PSVD Meeting

Hard endpoints in PSVD studies - Paris PSVD Meeting

Conditions associated with PSVD: impact on prognosis and treatment – Paris PSVD Meeting

Can PSVD regress - Paris PSVD Meeting

Can PSVD lead to cirrhosis - Paris PSVD Meeting

Table ronde – Single-cell omics et maladies rares du foie : échanges et perspectives – JR 2025

Round table – Single-cell omics and rare liver diseases: exchanges and perspectives – JR 2025

Table ronde – Sénescence cellulaire et maladies rares du foie : échanges et applications – JR 2025

Round table – Cellular senescence and rare liver diseases: exchanges and applications – JR 2025

Table ronde – Actualités des réseaux FILFOIE : échanges et discussions – JR 2025

Round table – News from the FILFOIE networks: exchanges and discussions – JR 2025